Post-Traumatic Hypopituitarism-Who Should Be Screened, When, and How?

Area of Science:

• Neuroendocrinology
• Trauma Surgery
• Public Health

Background:

• Traumatic brain injury (TBI) is a significant global health issue.
• Post-traumatic hypopituitarism (PTHP) is an increasingly recognized consequence of TBI.
• Underdiagnosis of PTHP is common due to non-specific symptoms and lack of standardized screening.

Purpose of the Study:

• To review the frequency and clinical significance of acute and chronic PTHP post-TBI.
• To examine the evidence supporting screening and hormone replacement therapy for PTHP.
• To propose a practical approach for identifying and managing anterior pituitary dysfunction after TBI.

Main Methods:

• Literature review of studies on TBI and PTHP.
• Analysis of evidence for screening protocols.
• Evaluation of hormone replacement strategies.
• Discussion of diagnostic and follow-up approaches.

Main Results:

• PTHP is a frequent and significant complication following TBI.
• Evidence supports the benefits of screening for and treating PTHP.
• Current literature provides a basis for managing pituitary dysfunction after TBI.

Conclusions:

• Early identification and management of PTHP are crucial for improving patient outcomes after TBI.
• Standardized screening and treatment protocols are needed.
• Further research is required to address remaining questions regarding PTHP.